H.C. Wainwright 28th Annual Global Investment Conference
New York, NY
Our RESETTM clinical trials with rese-cel (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, and pemphigus vulgaris are now recruiting.
New York, NY
Boston, MA
London, UK
Boston, MA